Silicone gel enhances the development of autoimmune disease in New Zealand black mice but fails to induce it in BALB/cAnPt mice

Clinical Immunology and Immunopathology

Volumn 87, Issue 3, 1998, Pages 248-255

  McDonald, Ann H ^a   Weir, Kimberly ^b   Schneider, Michelle ^a   Gudenkauf, Lynn ^a   Sanger, James R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

Autoimmunity; NZB mice; Silicone

Indexed keywords

SILICON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BREAST ENDOPROSTHESIS; CONTROLLED STUDY; HEMOLYSIS; IMMUNOGENICITY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031782564     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4532     Document Type: Article

References (50)

1. Varga J., Jimenez S. A. Augmentation mammoplasty and scleroderma. Arch. Dermatol. 126:1990;1220.
2. Kessler S. A. The basis of the Food and Drug Administration's implants. N. Engl. J. Med. 326:1992;1713.
3. Can. Med. Assoc. J. 147:1997;1141.
4. Englert H. J., Howe G. B., Penny R., Brooks P. Scleroderma and silicone breast implants. Br. J. Rheum. 33:1994;397.
5. Gabriel S. E., O'Fallon W. M., Kurland L. T., Beard C. M., Woods J. E. Risk of connective tissue diseases and other disorders after breast implantation. N. Engl. J. Med. 330:1994;1697.
6. Duffy M. J., Woods J. E. Health risks of failed silicone breast implants: a 30 year clinical experience. Plast. Reconstr. Surg. 94:1994;295.
7. Pidutti R., Morales A. Silicone gel filled testicular prosthesis and systemic disease. Urology. 42:1993;155.
8. Sanchez-Guerrero J., Colditz G. A., Karlson E. W., Hunter D. J., Speizer F. E., Liang M. H. Silicone breast implants and the risk of connective tissue diseases and symptom. N. Engl. J. Med. 332:1995;1666.
9. Silverman B. G., Brown S. L., Bright R. A., Kaczmarek R. G., Arrowsmith-Lowe J. B., Kessler D. A. Reported complication of silicone gel breast implants: an epidemiologic review. Ann. Int. Med. 124:1996;744.
10. Myoshi K., Miyoaka T., Kobayoshi U., Itakura T., Nishijo K., Higashibara M. Hypergammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty. Ijishimpo. 2122:1964;9.
11. Kumagai Y., Shiokawa Y., Medsger T. A. Jr., Rednan G. P. Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese Literature. Arth. Rheum. 27:1984;1.
12. Travis W. D., Balegh K., Abraham J. L. Silicone granulomas: report of three cases and review of the literature. Human Pathol. 16:1985;19.
13. Weisman M. H., Vecchione T. R., Albert D., Moore L. T., Mueller M. R. Connective tissue disease following breast augmentation: a preliminary test of the human adjuvant disease hypothesis. Plast. Reconst. Surg. 82:1988;626.
14. Varga J., Schumacher R., Jimenez S. A. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann. Int. Med. 111:1989;377.
15. Endo L. P., Edwards L., Longley S., Corman L. C., Panush R. S. Silicone and rheumatic diseases. Sem. Arth. Rheum. 17:1987;112.
16. Lin R. P., DiLeonardo M., Jacoby R. A. Silicone lymphadenopathy: a case report and review of the literature. Am. J. Dermatopathol. 15:1993;1.
17. Spiera R. F., Gibofsky A., Spiera H. Silicone-gel-filled breast implants and connective tissue disease: an overview. J. Rheum. 21:1994;239.
18. Houpt K. R., Sontheimer R. D. Autoimmune connective tissue disease and connective tissue disease-like illnesses after silicone gel augmentation mammoplasty. J. Am. Acad. Derm. 31:1994;626.
19. Sanchez-Guerrero J., Shur P. H., Sergent J. S., Liang M. H. Silicone breast implants and rheumatic disease. Arth. Rheum. 37:1994;158.
20. Naim J. O., Lanzafame R. J. The adjuvant effect of silicone gel on antibody formation in rats. Immunol. Invest. 22:1993;151.
21. McDonald A. H., Weir K., Sanger J. R. Silicone-induced T cell proliferation in mice. Curr. Topics Immunol. Microbiol. 210:1996;189-198.
22. Potter M., MacCardle R. C. Histology of developing plasma cell neoplasia induced by mineral oil in BALB/c mice. J. Natl. Cancer Inst. 49:1964;305.
23. Potter M., Morrison S., Weiner F., Zang X. K., Miller F. W. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. J. Natl. Cancer. Inst. 86:1994;1058.
24. Wooley P. H., Seibold J. R., Whalen J. D., Chapdelaine J. M. Pristane-induced arthritis: the immunologic and genetic features of an experimental murine model of autoimmune disease. Arthr. Rheum. 32:1989;1022.
25. Chang Y. H., Pearson C. M., Abe C. Adjuvant polyarthritus IV. Induction by a synthetic adjuvant: immunologic, histopathologic and other studies. Arth. Rheum. 23:1980;62.
26. Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:1985;269.
27. Yoshida S., Castles J. J., Gerschwin M. E. The pathogenesis of autoimmunity in New Zealand Mice. Sem. Arth. Rheum. 19:1990;224.
28. Morse H. C. III, Riblet R., Asofsky R., Weigert M. Plasmacytomas of the NZB mouse. J. Immunol. 121:1978;1969.
29. Potter M., Pumphrey J. G., Bailey D. W. Genetics of susceptibility of plasmacytoma induction. J. Natl. Cancer Inst. 54:1975;1413.
30. Yoshida S., Castles J. J., Gerschwin M. E. The pathogenesis of autoimmunity in New Zealand Mice. Sem. Arth. Rheum. 19:1990;224.
31. Nemecek J. A. R., Young L. How safe are silicone breast implants. South. Med. J. 86:1993;932.
32. Shah Z., Lehman J. A., Tan J. Does infection play a role in breast capsular contracture. Plast. Reconst. Surg. 68:1981;34.
33. Sanger J. R., Sheth N. K., Franson T. R. Adherence of microorganisms to breast prosthesis: an in vitro study. Ann. Plast. Surg. 22:1989;338.
34. Burkhardt B. R., Fried M., Schur P. L., Tofield J. J. Capsules, infections and intraluminal antibodies. Plast. Reconst. Surg. 68:1981;43.
35. Potter M., Wax J. S. Peritoneal plasmacytomagenesis in mice: comparison of different dose regimens. J. Natl. Cancer Inst. 71:1983;391-395.
36. Caulfield M. J., Stanko D., Calkins C. Characterization of the spontaneous autoimmune (anti-erythrocyte) response in NZB mice using a pathogenic monoclonal autoantibody and its anti-idiotype. Immunology. 66:1989;233-237.
37. Davidsohn I., Nelson D. A. The blood. Clinical Diagnosis by Laboratory Methods. 1974;W. B. Saunders, Philadelphia.
38. Hirose S., Nakanishi K., Yoshimoto T., Kashiwamura S., Hiroishi K., Matsumoto H. Identification and characterization of IL-2 hyper-responsive NZB/wH1 CD5-B cells. J. Immunol. 153:1994;1847-1857.
39. Kozono Y., Kotzin B. L., Holers V. M. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J. Immunol. 156:1996;4498-4503.
40. Sawchuk D. J., Mahmoudi M., Cairns E., Sinclair N. R. S. Nonsynonymous mutations in an Fc-receptor structural gene in NZB mice. Immunogenetics. 43:1995;112-133.
41. Perry F. E., Barker R. N., Mazza G., Day M. J., Wells A. D., Shen C. R. Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouse. Eur. J. Immunol. 26:1996;136.
42. Watanabe Y., Naiki M., Wilson T., Godfrey D., Chiang B-L., Boyd R. Thymic microenvironmental abnormalities and thymic selection in NZB.H-2bm12 mice. J. Immunol. 150:1993;4702-4712.
43. Reichlin M., Harley J. B. Antinuclear antibodies: an overview. Wallace D. J., Hahn B. H. Dubois Lupus Erythematosus. 1993;188 Lea & Febiger, Philadelphia.
44. Parker D. C. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:1993;331-360.
45. Bos N. A., Kimura H., Meeuwsen C. G., De Visser H., Hazenberg M. P., Wostmann B. S. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur. J. Immunol. 19:1989;2335-2339.
46. McDonald A. H., Byrd L. G., Mainhart C. R., Sopher J., Smith-Gill S. J. Plasmacytoma-refactory BALB/cAnPt mice have naive T cell and highly specific B cell responses to antigen. Mol. Immunol. 33:1996;1183-1196.
47. Dyrberg T. Molecular mimicry and diabetes. Curr. Top. Micro. Immunol. 145:1989;117-125.
48. Byrd L. G., McDonald A. H., Gold L., Potter M. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma production by pristane. J. Immunol. 147:1991;3632.
49. McDonald A. H., Degrassi A. Pristane induces an indomethacin inhibitable inflammatory infiltration of CD4+ T cells and IFN-γ production in plasmacytoma-susceptible BALB/cAnPt mice. Cell Immunol. 146:1993;157.
50. Deapen D., Escalante A., Weinrub L., Horwitz D., Bachman B., Roy-Burman P. A revised estimate of twin concordance in systemic lupus erythematosus. Arthr. Rheum. 36:1993;135-136.